GSK manufacturing woes continue
July 8, 2014Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing
Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …
Xellia expands in US with Fresenius Kabi buy
July 8, 2014Manufacturing and Production Fresenius Kabi, xellia
Anti-infective treatment provider Xellia has acquired Fresenius Kabi’s dedicated freeze-dried vial manufacturing facility in the US. The deal also includes …
Scottish Medicines Consortium disappoints Celgene
July 8, 2014Sales and Marketing Celgene, SMC, Scottish Medicines Consortium, imnovid, myeloma
Celgene admitted it is ‘disappointed’ with the Scottish Medicines Consortium decision not to recommend blood cancer therapy Imnovid for patients …
New director for Cello Health Insight
July 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, Kantar Health, marie innes
Healthcare market research agency Cello Health Insight has appointed Marie Innes as director. Based in the firm’s London head office …
Rise in diabetes ‘alarming’
July 7, 2014Sales and Marketing NHS, diabetes, nhs scotland, type 2
NHS Scotland has spent around £230 million on diabetes and obesity drugs in the past three years, according to data …
Mekinist shown EU green light
July 7, 2014Sales and Marketing CHMP, Cancer, GSK, Tafinlar, braf, mekinist, melanoma
The European Commission has given GlaxoSmithKline’s melanoma drug Mekinist the thumbs-up following a positive opinion in April from the European …
Alynlam secures fomer Pfizer head
July 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, alynlam, amy schulman
US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …
Spectrum wins FDA approval for rare cancer drug
July 4, 2014Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma
In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …
FDA clears St. Jude Medical
July 4, 2014Manufacturing and Production, Sales and Marketing CardioMEMS, FDA, california, st jude medical
US medical device manufacturer St. Jude Medical has been given a clean bill of health by the Food and Drug …
Unison warns of ‘dangerous’ £1 billion NHS tender
July 4, 2014Sales and Marketing CCG, England, NHS, commissioning, unison
A row is bubbling over the provision of health services in Staffordshire after a trade union accused four NHS clinical …
Pharmalink elects three to board
July 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab
Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …
Majority of consumed Viagra fake say researchers
July 3, 2014Manufacturing and Production, Sales and Marketing BMJ, ED, Pfizer, Sildenafil, counterfeit, erectile dysfunction, viagra
At least two-thirds of Pfizer’s erectile dysfunction drug Viagra used in the Netherlands may be illegal, researchers are warning. In …
Novartis faces data fraud charges in Japan
July 3, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan
Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …
Genentech to buy Seragon
July 3, 2014Sales and Marketing Genentech, Roche, breast cancer, oncology, serds
Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …
Prosensa makes two key appointments


July 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prosensa, Willem W. van Weperen. Annalisa Jenkins
Dutch biopharma firm Prosensa has appointed Willem W. van Weperen as chief commercial officer and Dr Annalisa Jenkins to its …
World facing medical ‘dark ages’ over antibiotic resistance
July 2, 2014Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance
The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …
FDA breakthrough for Amgen
July 2, 2014Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia
Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …
J&J completes $4 billion OCD sale
July 2, 2014Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd
Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
